Approval · Notice of Compliance 11008 · 2010
RIDAURA: Notice of Compliance 11008
Issued February 5, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11008
- Date
- February 5, 2010
- Company
- Xediton Pharmaceuticals Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antirheumatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIDAURA | 01916823 | Marketed |
Medicinal ingredients
- AURANOFIN 3 MG per CAP